Abstract: The present disclosure provides a model training method and apparatus, a model testing method and apparatus, and a storage medium. The model training method includes: receiving a training request of a second device of a management service consumer, where the training request carries a training attribute, the training attribute includes: training indication information, the training indication information is used to indicate an association relationship between multiple models and a model generation strategy; and establishing a configuration instance in a first device, and jointly training the multiple models to obtain a training result according to the training indication information and multiple model identifiers of the training attribute, where the training result includes a trained fusion model.

Abstract: Embodiments of the present disclosure provide a model monitoring method, a monitoring end, a device, and a storage medium. The method includes obtaining model related information of a first target model; and obtaining a model performance prediction analysis result on the basis of the model related information, wherein the model performance prediction analysis result is configured for indicating whether to update the first target model.

Abstract: A touch display panel and an electronic equipment are provided. The touch display panel includes a display area and a non-display area. The touch display panel also includes a touch function layer, a thin film transistor array layer, and an organic light emitting layer. Using a preparation process of the thin film transistor array layer, a touch wiring of the non-display area is formed on a same layer, which can solve a problem of poor etching of the touch wiring due to different substrate materials of a touch trace in the display area and the touch wiring in the non-display area.

Abstract: The present application provides a charging method, a user equipment and a network-side equipment. The method comprises: acquiring, by a user equipment, charging information of a quality of service (QoS) flow, wherein the charging information is generated based on a proximity based service provided by the user equipment; and transmitting the charging information to a network-side equipment, wherein the charging information comprises flow information of the QoS flow.

Abstract: A touch display panel and an electronic equipment are provided. The touch display panel includes a display area and a non-display area. The touch display panel also includes a touch function layer, a thin film transistor array layer, and an organic light emitting layer. Using a preparation process of the thin film transistor array layer, a touch wiring of the non-display area is formed on a same layer, which can solve a problem of poor etching of the touch wiring due to different substrate materials of a touch trace in the display area and the touch wiring in the non-display area.

Abstract: A display panel and a display device are provided, and the display panel includes a bonding area, a thin film transistor functional layer, and a conductive structure layer disposed in order. A part of the thin film transistor functional layer disposed on the bonding area includes a first inorganic layer and a plurality of signal lines. The conductive structure layer includes a second inorganic layer and a conductive layer disposed in order, and a part of the second inorganic layer disposed in the bonding area is disposed on the signal line and is directly disposed on the first inorganic layer.

Abstract: A display panel and a display device are provided, and the display panel includes a bonding area, a thin film transistor functional layer, and a conductive layer disposed in order. A part of the thin film transistor functional layer disposed on the bonding area includes a first inorganic layer and a plurality of signal lines. The conductive layer includes a second inorganic layer and a conductive layer disposed in order, and a part of the second inorganic layer disposed in the bonding area is disposed on the signal line and is directly disposed on the first inorganic layer.

Abstract: There is provided a method including determining for a plurality of baseband units, in dependence on one or more parameters, which radio access technology is supported by a respective base band unit and causing said baseband unit to operate in said respective radio access technology.

Abstract: The present invention is directed to compounds of the Formula I as well as pharmaceutically acceptable salts thereof, that are useful for treating aldosterone-mediated diseases. The invention furthermore relates to processes for preparing compounds of the Formula I, to their use for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical compositions which comprise compounds of the Formula I.

Abstract: Compounds of structural formula I are inhibitors of prolylcarboxypeptidase (PrCP). The compounds of the present invention are useful for the prevention and treatment of conditions related to the enzymatic activity of PrCP such as abnormal metabolism, including obesity; diabetes; metabolic syndrome; obesity related disorders; and diabetes related disorders.

Abstract: The present invention is directed to compounds of the Formula I as well as pharmaceutically acceptable salts thereof, that are useful for treating aldosterone-mediated diseases. The invention furthermore relates to processes for preparing compounds of the Formula I, to their use for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical compositions which comprise compounds of the Formula I.

Abstract: Disclosed are the compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, which are useful for treating aldosterone-mediated diseases. The processes for preparing compounds of the Formula (I), the use for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and the pharmaceutical compositions which comprise compounds of the formula (I) are disclosed too.

Abstract: Compounds of structural formula (I) are inhibitors of prolylcarboxypeptidase (PrCP). The compounds of the present invention are useful for the prevention and treatment of conditions related to the enzymatic activity of PrCP such as abnormal metabolism, including obesity; diabetes; metabolic syndrome; obesity related disorders; and diabetes related disorders.

Abstract: Disclosed are the compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, which are useful for treating aldosterone-mediated diseases. The processes for preparing compounds of the Formula (I), the use for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and the pharmaceutical compositions which comprise compounds of the formula (I) are disclosed too.